You have 9 free searches left this month | to do more

talquetamab

Talquetamab is a drug used to treat Multiple Myeloma and Hematological Malignancies. Talquetamab is being actively studied in 6 studies; no studies for this drug have been completed so far.

Top SponsorsTop SitesTop Investigators
Janssen Research & Development, LLCClinica Univ. de Navarra
Janssen Pharmaceutical K.K.Hosp. Clinico Univ. de Salamanca
Hosp. Univ. Fund. Jimenez Diaz
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
J
A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
  • Multiple Myeloma
  • Talquetamab
  • +2 more
  • Edmonton, Alberta, Canada
  • +12 more
2021-10-07
Oct 7, 2021
J
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
  • Hematological Malignancies
  • Talquetamab
  • Birmingham, Alabama
  • +14 more
2021-10-07
Oct 7, 2021
J
A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Not yet recruiting
  • Multiple Myeloma
  • Talquetamab
  • +4 more
  • Birmingham, Alabama
  • +30 more
2021-09-10
Sep 10, 2021
J
A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
  • Multiple Myeloma
  • Talquetamab
  • Nagoya, Japan
  • +3 more
2021-10-07
Oct 7, 2021
J
A Study of Subcutaneous Daratumumab Regimens in Combination With Bispecific T Cell Redirection Antibodies for the Treatment of Participants With Multiple Myeloma
Recruiting
  • Multiple Myeloma
  • Duarte, California
  • +24 more
2021-10-07
Oct 7, 2021
J
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
  • Hematological Malignancies
  • Talquetamab
  • Birmingham, Alabama
  • +79 more
2021-10-07
Oct 7, 2021